Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or call +44 (0)1344 864796.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? You can contact our Delegate Relations team at delegate.relations@forumsupport.co.uk or by calling the above number.

Next steps for vaccine research, development, and rollout - Learning lessons from the pandemic response, supporting innovation, and encouraging research partnerships

Morning, Monday, 21st February 2022


This conference will examine next steps for vaccine research, development, and rollout.


Areas for discussion include:

  • lessons that can be learned from the COVID-19 vaccination programme to inform the development of future vaccines and treatments
  • the role, development, and use of booster and second generation COVID-19 vaccines as a fourth wave of COVID-19 spreads through Europe
  • harnessing innovation within vaccinology to boost research and improve outcomes - learning from:
    • the rapid rollout of Messenger RNA (mRNA) vaccines during the pandemic
    • research partnerships developed across the public and private sector as a response to the pandemic
  • priorities for delivering an effective malaria vaccination programme
    • utilisation of global networks and supply chains that have been put in place during the pandemic
    • learning from what has worked internationally 
  • the global rollout of COVID-19 vaccines, and ensuring new, innovative vaccines are accessible to all

There will also be an opportunity to assess priorities for action beyond the COVID-19 pandemic - looking at what has been learned that can be applied more widely to progress on vaccines and considering key issues for policy, regulation, and industry action.


We are pleased to be able to include keynote sessions on:

  • Opportunities for taking forward recent achievements in vaccine research and development - with Dr Doug Brown, Chief Executive, British Society for Immunology
  • Driving forward COVID-19 vaccine research and development - with Professor Andrew Ustianowski, National Clinical Lead, COVID Vaccine Research Programme, NIHR 
  • Global rollout and accessibility of COVID-19 vaccines and other innovative developments - with Dr Alejandro Cravioto, Chair, Strategic Advisory Group of Experts on Immunisation, WHO

The discussion is bringing together stakeholders with key policy officials who are due to attend from the DHSC; the MHRA; and the UK Health Security Agency.



Keynote Speakers

Dr Doug Brown

Chief Executive, British Society for Immunology

Dr Alejandro Cravioto

Chair, Strategic Advisory Group of Experts on Immunisation, World Health Organisation

Professor Andrew Ustianowski

National Clinical Lead, COVID Vaccine Research Programme, NIHR; and Consultant and Research Lead in Infectious Diseases and Tropical Medicine, North Manchester General Hospital

Keynote Speakers

Professor Andrew Ustianowski

National Clinical Lead, COVID Vaccine Research Programme, NIHR; and Consultant and Research Lead in Infectious Diseases and Tropical Medicine, North Manchester General Hospital

Dr Alejandro Cravioto

Chair, Strategic Advisory Group of Experts on Immunisation, World Health Organisation

Dr Doug Brown

Chief Executive, British Society for Immunology

Chair

Lord Oates

Vice Chair, All-Party Parliamentary Group on Vaccinations for All

Speakers

Professor Daniela Ferreira

Professor of Respiratory Vaccines and Infection Immunology and Head of Department of Clinical Sciences, Liverpool School of Tropical Medicine

Jenny Lippiatt

Professionals and Practice Programme Manager, Age UK

Richard Sloggett

Founder and Programme Director, Future Health Research; and former Special Advisor to the Secretary of State for Health and Social Care

Dr Andrew Allen

President, Gritstone bio

Professor Robin Shattock

Head of Mucosal Infection and Immunity, Department of Medicine, Imperial College London

Tahir Amin

Intellectual Property Lawyer, Co-Founder and Co-Executive Director, I-MAK

Professor Tim Elliott

Kidani Professor of Immuno-oncology and Fellow of Oriel College, University of Oxford

Professor Teresa Lambe

Principal Investigator and Associate Professor, The Jenner Institute, University of Oxford